Private equity led the way in terms of alternative investment fundraising, accounting for 61% of the $740bn of global asset allocations made in in the year ended 31 March 2023, according to a new report by Dasseti and Alternatives Watch. The 2023 Manager Compendium research report, which covers six asset
US public pensions have increased their exposure to private equity to $622bn, the highest in at least two decades, as part of an overall record $1.6tn investment in alternative assets, according to a report by Bloomberg.
KKA Partners, a Berlin-based private equity firm that invests in DACH based SME companies, and grows enterprises through technology enablement, has closed its second fund with €230 million in external capital commitments.
Davidson Kempner Capital Management has closed its Davidson Kempner Opportunities Fund VI, which will target investments in less liquid, longer-duration situations arising from capital dislocations, motivated sellers, and substantial asset or structural complexity, with $3bn in capital commitments. The five previous vintages of the fund have collectively invested over $10bn
LGT Capital Partners has held the final close of Crown Growth Opportunities IV (CGR IV), the firm’s fourth global venture capital fund, with more than $930m in capital commitments – in excess of its original $750m target.Â
Vertex Ventures HC, a women-led global healthcare investment firm, has launched its third and largest fund, the $200 million Fund III, which will focus on backing life sciences and medical technology companies aiming to drive innovation and improve patient outcomes.
Alpine Investors, a Certified B-Corp private equity firm focused on investments in software and services companies, has completed fundraising for Alpine Investors IX at the fund’s hard cap of $4.5bn in limited partner capital commitments.
Shore Capital Partners, a private equity firm focused on microcap investments, has closed its inaugural Industrial fund, Shore Capital Industrial Partners Fund I, and its fifth healthcare fund, Shore Capital Healthcare Partners Fund V, with a combined $643m in capital commitments.
The Riverside Company, a global private investment firm focused on the smaller end of the middle market, has held the final close of the Riverside Value Fund I (RVF I), at its target of $350 million in capital commitments.
RCP Advisors, a sponsor of private equity funds-of-funds, secondary funds, and co-investment funds focused on North American lower middle market buyouts, has held the final close of the RCP Secondary Opportunity Fund IV with $797m in capital commitments, ahead of its $500m target.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
